NM_001048174.2(MUTYH):c.379-3T>C AND Familial adenomatous polyposis 2

Germline classification:: Uncertain significance (2 submissions)
Last evaluated:: Oct 9, 2023
Review status:: 2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV000524907.8

Allele description [Variation Report for NM_001048174.2(MUTYH):c.379-3T>C]

NM_001048174.2(MUTYH):c.379-3T>C

Gene:

MUTYH:mutY DNA glycosylase [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

1p34.1

Genomic location:

Preferred name:

NM_001048174.2(MUTYH):c.379-3T>C

HGVS:

NC_000001.11:g.45332962A>G
NG_008189.1:g.12509T>C
NM_001048171.2:c.379-3T>C
NM_001048172.2:c.382-3T>C
NM_001048173.2:c.379-3T>C
NM_001048174.2:c.379-3T>CMANE SELECT
NM_001128425.2:c.463-3T>C
NM_001293190.2:c.424-3T>C
NM_001293191.2:c.412-3T>C
NM_001293192.2:c.103-3T>C
NM_001293195.2:c.379-3T>C
NM_001293196.2:c.103-3T>C
NM_001350650.2:c.34-3T>C
NM_001350651.2:c.34-3T>C
NM_012222.3:c.454-3T>C
LRG_220t1:c.463-3T>C
LRG_220:g.12509T>C
NC_000001.10:g.45798634A>G
NM_001128425.1:c.463-3T>C

Links:

dbSNP: rs770203030

NCBI 1000 Genomes Browser:

rs770203030

Molecular consequence:

NM_001048171.2:c.379-3T>C - intron variant - [Sequence Ontology: SO:0001627]
NM_001048172.2:c.382-3T>C - intron variant - [Sequence Ontology: SO:0001627]
NM_001048173.2:c.379-3T>C - intron variant - [Sequence Ontology: SO:0001627]
NM_001048174.2:c.379-3T>C - intron variant - [Sequence Ontology: SO:0001627]
NM_001128425.2:c.463-3T>C - intron variant - [Sequence Ontology: SO:0001627]
NM_001293190.2:c.424-3T>C - intron variant - [Sequence Ontology: SO:0001627]
NM_001293191.2:c.412-3T>C - intron variant - [Sequence Ontology: SO:0001627]
NM_001293192.2:c.103-3T>C - intron variant - [Sequence Ontology: SO:0001627]
NM_001293195.2:c.379-3T>C - intron variant - [Sequence Ontology: SO:0001627]
NM_001293196.2:c.103-3T>C - intron variant - [Sequence Ontology: SO:0001627]
NM_001350650.2:c.34-3T>C - intron variant - [Sequence Ontology: SO:0001627]
NM_001350651.2:c.34-3T>C - intron variant - [Sequence Ontology: SO:0001627]
NM_012222.3:c.454-3T>C - intron variant - [Sequence Ontology: SO:0001627]

Observations:

Condition(s)

Name:: Familial adenomatous polyposis 2
Synonyms:: COLORECTAL ADENOMATOUS POLYPOSIS, AUTOSOMAL RECESSIVE; ADENOMAS, MULTIPLE COLORECTAL, AUTOSOMAL RECESSIVE; MYH-associated polyposis; See all synonyms [MedGen]
Identifiers:: MONDO: MONDO:0012041; MedGen: C3272841; Orphanet: 220460; OMIM: 608456

Recent activity

Clear Turn Off Turn On

Homo sapiens SNAP associated protein (SNAPIN), transcript variant 2, non-coding ...
Homo sapiens SNAP associated protein (SNAPIN), transcript variant 2, non-coding RNA
gi|392508157|ref|NR_052019.1|

Nucleotide

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV000639326	Labcorp Genetics (formerly Invitae), Labcorp	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Uncertain significance (Oct 9, 2023)	germline	clinical testing	PubMed (3) [See all records that cite these PMIDs] 17576681, 9536098, 28492532
SCV004834182	All of Us Research Program, National Institutes of Health	criteria provided, single submitter (ACMG Guidelines, 2015)	Uncertain Significance (Aug 15, 2023)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV000639326

Labcorp Genetics (formerly Invitae), Labcorp

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Uncertain significance
(Oct 9, 2023)

germline

clinical testing

PubMed (3)
[See all records that cite these PMIDs]

SCV004834182

All of Us Research Program, National Institutes of Health

criteria provided, single submitter

(ACMG Guidelines, 2015)

Uncertain Significance
(Aug 15, 2023)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	1	not provided	not provided	108544	not provided	clinical testing

Citations

PubMed

Aberrant 5' splice sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization.

Buratti E, Chivers M, Královicová J, Romano M, Baralle M, Krainer AR, Vorechovsky I.

Nucleic Acids Res. 2007;35(13):4250-63. Epub 2007 Jun 18.

PubMed [citation]

PMID:: 17576681
PMCID:: PMC1934990

Statistical features of human exons and their flanking regions.

Zhang MQ.

Hum Mol Genet. 1998 May;7(5):919-32.

PubMed [citation]

PMID:: 9536098

See all PubMed Citations (4)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000639326.5

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (3)

Description

This sequence change falls in intron 5 of the MUTYH gene. It does not directly change the encoded amino acid sequence of the MUTYH protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs770203030, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with MUTYH-related conditions. ClinVar contains an entry for this variant (Variation ID: 464723). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that this variant is associated with altered splicing resulting in unknown protein product impact (Invitae). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

From All of Us Research Program, National Institutes of Health, SCV004834182.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	1	not provided	not provided	clinical testing	PubMed (1)

Description

This variant causes a T to C nucleotide substitution at the -3 position of intron 5 of the MUTYH gene. To our knowledge, RNA studies have not been reported for this variant. This variant has not been reported in individuals affected with MUTYH-related disorders in the literature. This variant has been identified in 1/250382 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	108544	not provided	not provided		1	not provided	not provided	not provided

Last Updated: Sep 29, 2024

ClinVar

Relating variation to medicine